Flexiciser International Makes a Donation to Johns Hopkins Medicine
Carlsbad, CA, October 06, 2008 --(PR.com)-- Flexiciser International is proud to announce the donation of its innovative movement therapy product--- the All Stainless-Steel Flexiciser Professional to Johns Hopkins Medicine.
Due to increased demand from various institutions and health care facilities, the Flexiciser Professional is designed specifically for mobility challenged individuals and is designed to withstand use by multiple users. This new Flexiciser Professional utilizes the latest state-of-the-art technology and many health care facilities are choosing to update to this latest model for their patients and clients.
Mr. Arthur M. Kassel, Chairman, Founder and CEO: "We are very excited to donate this state of the art product to Johns Hopkins Medicine. The Flexiciser technology will provide an incredible rehabilitation option for wheel chair users."
Since 1982, Flexiciser has designed motorized exercise products for the mobility challenged, including paraplegics, quadriplegics, and individuals who can not maintain movement through natural means. Loss of movement has severe consequences, both physically and mentally. The Flexiciser provides a clinically tested method for increasing Cardiovascular health, increasing Range of Motion (ROM) and decreasing Pain. The peer-reviewed Flexiciser Clinical Trials were recently published in the Journal of Spinal Cord Medicine.
Thousands of people have used the Flexiciser to improve their physical and mental states. Patients include those afflicted by Spinal Cord Injury, Head Injury, Multiple Sclerosis, Parkinson’s disease, Muscular Dystrophy, Cerebral Palsy, and other muscle-degenerative diseases.
According to Karen Pinson, Physical Therapist of In Home Health Care of Los Angeles County, “the Flexiciser would be specifically advantageous for patients with neuromuscular problems, such as the early stages of Parkinson’s disease. Other diagnoses that are orthopedic related, total hip replacement, total knee replacement, total shoulder replacement, arthroscopic surgery, and arthritis, would experience physical benefits from the usage of the equipment. Finally, the Flexiciser is excellent for cardiovascular rehabilitation, particularly for those patients who are recovering from a CABG or Myocardial Infarction.”
About Flexiciser International
Since 1982, Flexiciser has impacted thousands of people with mobility challenges. Flexiciser is the only technology to offer natural elongated stride, full range of motion, non-weight baring on joints and movement of upper and lower extremities simultaneously, even for quadriplegics. The technology is FDA, UL and VA approved, patented and trademarked. The company’s products are benefiting thousands of individuals and rehabilitation facilities working with SCI, TBI, Multiple Sclerosis, Stroke, CP, Spinal Bifida, Parkinson’s, Muscular Dystrophy and more.
About Johns Hopkins Medicine
The mission of Johns Hopkins Medicine is to improve the health of the community and the world by setting the standard of excellence in medical education, research and clinical care. Based in Baltimore, MD, Johns Hopkins manages over 82,500 annual Admissions and employs nearly 26,000 employees. Diverse and inclusive, Johns Hopkins Medicine educates medical students, scientists, health care professionals and the public; conducts biomedical research; and provides patient-centered medicine to prevent, diagnose and treat human illness. The Johns Hopkins Hospital has once again — for the 18th consecutive time — earned the top spot in U.S.News & World Report’s annual rankings of American hospitals, placing first in three medical specialties and very high in 12 others.
###
Due to increased demand from various institutions and health care facilities, the Flexiciser Professional is designed specifically for mobility challenged individuals and is designed to withstand use by multiple users. This new Flexiciser Professional utilizes the latest state-of-the-art technology and many health care facilities are choosing to update to this latest model for their patients and clients.
Mr. Arthur M. Kassel, Chairman, Founder and CEO: "We are very excited to donate this state of the art product to Johns Hopkins Medicine. The Flexiciser technology will provide an incredible rehabilitation option for wheel chair users."
Since 1982, Flexiciser has designed motorized exercise products for the mobility challenged, including paraplegics, quadriplegics, and individuals who can not maintain movement through natural means. Loss of movement has severe consequences, both physically and mentally. The Flexiciser provides a clinically tested method for increasing Cardiovascular health, increasing Range of Motion (ROM) and decreasing Pain. The peer-reviewed Flexiciser Clinical Trials were recently published in the Journal of Spinal Cord Medicine.
Thousands of people have used the Flexiciser to improve their physical and mental states. Patients include those afflicted by Spinal Cord Injury, Head Injury, Multiple Sclerosis, Parkinson’s disease, Muscular Dystrophy, Cerebral Palsy, and other muscle-degenerative diseases.
According to Karen Pinson, Physical Therapist of In Home Health Care of Los Angeles County, “the Flexiciser would be specifically advantageous for patients with neuromuscular problems, such as the early stages of Parkinson’s disease. Other diagnoses that are orthopedic related, total hip replacement, total knee replacement, total shoulder replacement, arthroscopic surgery, and arthritis, would experience physical benefits from the usage of the equipment. Finally, the Flexiciser is excellent for cardiovascular rehabilitation, particularly for those patients who are recovering from a CABG or Myocardial Infarction.”
About Flexiciser International
Since 1982, Flexiciser has impacted thousands of people with mobility challenges. Flexiciser is the only technology to offer natural elongated stride, full range of motion, non-weight baring on joints and movement of upper and lower extremities simultaneously, even for quadriplegics. The technology is FDA, UL and VA approved, patented and trademarked. The company’s products are benefiting thousands of individuals and rehabilitation facilities working with SCI, TBI, Multiple Sclerosis, Stroke, CP, Spinal Bifida, Parkinson’s, Muscular Dystrophy and more.
About Johns Hopkins Medicine
The mission of Johns Hopkins Medicine is to improve the health of the community and the world by setting the standard of excellence in medical education, research and clinical care. Based in Baltimore, MD, Johns Hopkins manages over 82,500 annual Admissions and employs nearly 26,000 employees. Diverse and inclusive, Johns Hopkins Medicine educates medical students, scientists, health care professionals and the public; conducts biomedical research; and provides patient-centered medicine to prevent, diagnose and treat human illness. The Johns Hopkins Hospital has once again — for the 18th consecutive time — earned the top spot in U.S.News & World Report’s annual rankings of American hospitals, placing first in three medical specialties and very high in 12 others.
###
Contact
Flexiciser
Heli Rytkonen
760.759.1303
www.flexiciser.com
Heli Rytkonen
760.759.1303
www.flexiciser.com
Contact
Categories